The largest database of trusted experimental protocols

15 protocols using ppre x3 tk luc

1

Transfection and Luciferase Assay for PPARγ2

Check if the same lab product or an alternative is used in the 5 most similar protocols
HEK-293 cells were seeded and co-transfected with plasmids pBabe bleo human PPARγ2 and PPRE X3-TK-luc (Addgene) in 384-well plate and incubated for 16 h. Compounds (100, 10, 1, 0.1, 0.01, 0.001μM) were added and then incubated another 24h. Cell lysates were then analyzed for luciferase activity with Bright-Glo Luciferase kit (Promega). Luminescence was measured using a plate reader.
+ Open protocol
+ Expand
2

Dual-glo Luciferase Assay for PPAR-γ Activity

Check if the same lab product or an alternative is used in the 5 most similar protocols
+SA, MCF-7, and MDA-MB-231 cells were plated at a density of 2 × 104 cells/well (3 replicates per group) in 96-well plates and allowed to adhere overnight. After this cells were transfected with 32 ng of PPRE X3-TK-luc (Addgene plasmid no.1015) [31 (link)] and 3.2 ng of Renilla luciferase plasmid per well (Promega E2261) and then cotransfected with scrambled or PPARγ siRNAs using 0.8 μL of lipofectamine 2000 transfection reagent for each well. After 6 h transfection, the media were removed; the cells were washed once and exposed to 100 μL of treatment media containing 3.2 μM rosiglitazone and GW9662 or 2 μM γ-tocotrienol alone or in combination for a 4-day culture period. Afterwards, cells were lysed with 75 μL of passive lysis buffer and treated according to manufacturer's instructions using dual-glo luciferase assay system (Promega E2920). Luciferase activity of each sample was normalized by the level of Renilla activity. Data is represented as mean fold changes in treated cells as compared to control cells.
+ Open protocol
+ Expand
3

Monitoring PPAR Transcriptional Activity

Check if the same lab product or an alternative is used in the 5 most similar protocols
PPAR transcriptional activity was monitored in vitro using a reporter construct consisting of three PPRE copies upstream of a luciferase reporter. At day 5 of differentiation, BAs differentiated from immortalized SVF were transiently transfected with the following plasmids using X-tremeGENE: PPREx3-TK-luc (Addgene#1015), pRL-TK (control Renilla), HA-p62, HA-NBR1 or Flag-PPARγ1 (Addgene#78769). The level of promoter activity was evaluated by determining the firefly luciferase activity relative to renilla luciferase activity using the Dual Luciferase Assay System (Promega) according to the manufacturer’s instruction.
+ Open protocol
+ Expand
4

Evaluating PPAR Activation Pathways

Check if the same lab product or an alternative is used in the 5 most similar protocols
Ciprofibrate and rosiglitazone 1, were obtained from Cayman Chemical (Ann Arbor, MI). Dulbecco's Modified Eagle's Medium (DMEM), fetal bovine serum (FBS) and phosphate-buffered saline (PBS) were purchased from Hyclone (South Logan, Utah). Penicillin/streptomycin and trypsin were procured from Gibco (Grand Island, NY). Specific plasmids pSG5–PPARα (plasmid 22751) and PPRE X3-tk-luc (plasmid 1015) were obtained from Addgene (Cambridge, MA). pCMV-rPPARγ and pPPREaP2-tk-luc were provided by Dr. Dennis Feller (Department of Pharmacology, University of Mississippi).
+ Open protocol
+ Expand
5

Transcriptional Regulation of PPARs

Check if the same lab product or an alternative is used in the 5 most similar protocols
To investigate the transcriptional activity of PPARs, we used a peroxisome proliferator response element (PPRE)-driven luciferase reporter gene approach (Kim et al., 1998 (link)). In brief, CHO cell lines were transfected with a reporter construct containing three copies of the PPRE placed upstream of the thymidine kinase promoter- firefly luciferase fusion gene (PPRE X3-TK-luc, Addgene plasmid #1015). In addition, the cells were transfected with a cytomegalovirus promoter-driven Renilla luciferase reporter gene (pGL4.75 hRluc/CMV, Promega, E6931) used as transfection control. Where indicated, transfectants were treated with 5 µM of rosiglitazone (Sigma, R2408) or with conditioned medium containing 5 µg/ml of human apoE3 or apoE4 for 24 h. At 24 to 48 h after transfection, cells were lysed in buffer (50 mM Tris-HCl, pH 7.4, 140 mM NaCl and 1% Triton X-100) and lysates used to assay luciferase activity in 96-well plates using the Dual-Luciferase Reporter Assay (Promega) according to the manufacturer's instructions. The luminescence-based PPAR activity (firefly luciferase) was normalized to the internal Renilla luciferase activity.
+ Open protocol
+ Expand
6

PPARγ Activation Assay in 3T3-L1 and HEK-293 Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
The 3T3-L1 mouse fibroblasts and HEK-293 (ATCC, Manassas, VA, USA) were maintained at 37 °C in a 5% CO2, humidified atmosphere. The cells were cultured in Dulbecco's modified Eagle's medium (DMEM), containing 4.5 g/L glucose with 10% fetal bovine serum (FBS; HyClone, Logan, UT, USA). PolarScreen™ PPARγ-Competitor Assay Kit was purchased from Thermo Fisher Scientific (Waltham, US). Bright-Glo™ Luciferase Assay System was purchased from Promega (Madison, US). Oil Red O was purchased from Alfa Aesar (Haverhill, MA, USA). Rosiglitazone was purchased from Sigma. UHC1 and WO95E were synthesized in-house. DMSO was used as solvent and as vehicle control at 0.1% in cell-based assays. Plasmids pBabe bleo human PPARγ2 (#11439) and PPRE X3-TK-luc (#1015) were acquired from Addgene.
+ Open protocol
+ Expand
7

CYP1B1 Regulation of Tight Junctions and MAO-B

Check if the same lab product or an alternative is used in the 5 most similar protocols
The fragments encoding CYP1B1 and KLF11 were cloned into the pcDNA3.1 (+) vector. The fragment encoding PPARγ was cloned into the pSG5 vector. The luciferase reporter PPAR response element (PPRE) X3‐TK‐Luc was obtained from Addgene (Watertown, MA). All the constructs were verified by DNA‐sequence analysis. To investigate the regulation of tight junctions by CYP1B1, hCMEC/D3 cells were transiently transfected with CYP1B1 or PPARγ expression vector for 24 h. To investigate the regulation of MAO‐B by CYP1B1, SH‐SY5Y cells were transiently transfected with the CYP1B1 or KLF11 expression vector for 24 h. The respective empty vectors were used as the control.
To investigate the effects of HETEs on PPARγ transcriptional activity, hCMEC/D3 cells were treated with 5‐HETE (1 μM) and 15‐HETE (1 μM) following co‐transfection with PPRE luciferase reporter and PPARγ expression vector for 24 h. The luciferase activity was determined using the Dual‐Luciferase Reporter Assay kit (Promega, Madison, WI, USA), and the firefly luciferase activity was normalized to the Renilla luciferase activity.
+ Open protocol
+ Expand
8

Measuring PPARα Activity in HepG2 Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
To measure PPARα activity, HepG2 cells were seeded in 96-well plates and transfected with PPRE X3-TK-luc and pRL-SV40P plasmids (Cat# 1015 and 27163, respectively; Addgene, Watertown, MA, USA) at a ratio of 1:40 using lipofectamine 3000 (Cat# L3000-001; Invitrogen), according to the manufacturer's protocol. Transfected cells were treated with ACEA at a final concentration of 10 μM for 24 h. Luciferase activity was measured using a Dual-Glo Luciferase assay system (Cat# E2920; Promega, Madison, WI, USA) according to the manufacturer's protocol.
+ Open protocol
+ Expand
9

Transient Transfection Assay for PPAR and RXR

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cos-7 cells (in 96 well plates) were transiently transfected with vectors containing mouse Pparg1 (plasmid 8886; Addgene, Cambridge, MA) or mouse Pparg2 (plasmid 8862; Addgene), with human RXRA (plasmid 8882; Addgene) (Tontonoz et al., 1994 (link)), PPRE x3-TK-luc (plasmid 1015; Addgene) (Kim et al., 1988), and CMV-eGFP using Lipofectamine 2000 (Invitrogen, Carlsbad, CA). Transfected cultures were incubated overnight. The medium was replaced, and cultures received no treatment (Naïve) or were treated with Vh (DMSO, 0.1%), rosiglitazone, TBT, TPhT, METBP, MEHP, TBBPA at concentrations ranging from 0.1 nM to 400µM and incubated for 24 hrs. Cells were lysed in Glo Lysis Buffer (Promega, Madison, WI), to which Bright Glo Reagent (Promega) was added. Luminescence and fluorescence were determined using a Synergy2 plate reader. Luminescence was normalized by the GFP fluorescence in the same well. The normalized luminescence for each well was then divided by the normalized luminescence measured in transfected but untreated wells to determine the “Fold Change from Naive.”
+ Open protocol
+ Expand
10

Transfection of Luciferase Reporters

Check if the same lab product or an alternative is used in the 5 most similar protocols
The PPRE X3-TK-luc plasmid was purchased from Addgene (No. 1015). 30,000 cells were seeded into 24 well plates and transfected with 1μg of PPRE X3-TK-luc and 100ng of Renilla luciferase plasmids using Fugene 6 (Promega). Luciferase activity was measured two days after transfection using the Dual Luciferase assay kit (Promega).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!